Moderated by Axios, panelists discussed the promise of these therapies, the risks and regulatory challenges surrounding non-FDA-approved compounded versions, and what the next phase could mean for patients, providers, policymakers, and industry
These may include nausea, decreased appetite, vomiting, constipation, diarrhea, bloating, or abdominal discomfort
Connolly BD, Petry C, Yadav S, Demeule B, Ciaccio N, Moore JR, Shire S, Gokarn Y
The trials showed meaningful weight loss at every dose level
Cancer prevention research (Philadelphia, Pa.)
Additionally, it improved PD Quality of Life Scale scores, thereby enhancing motor function, cardiorespiratory endurance, and overall quality of life (Zanchet et al., 2025)